Quantcast

Latest Thrombosis Stories

2014-04-23 20:23:33

The realities of modern life can make people more susceptible to deep vein thrombosis, but the California Institute for Deep Venous Thrombosis offers effective solutions LOS ANGELES, April 23, 2014 /PRNewswire/ -- Due to our sedentary modern lifestyle, deep vein thrombosis (DVT) is a growing issue. DVT - a condition in which a person suffers from a blood clot in leg - is much more likely to occur if you're sitting still for a long time. With so many people sitting in front of television and...

2014-04-14 12:33:30

Epidemiological, genetic and clinical data presented today at the International Liver CongressTM 2014 are collectively focused on different approaches designed to improve the diagnosis, staging and treatment of hepatocellular carcinoma (HCC). "Human hepatocellular carcinoma is one of the most prevalent cancers worldwide and the second most frequent cause of cancer-related death," said EASL's Scientific Committee Member Dr Helen Reeves Senior Lecturer & Honorary Consultant...

2014-04-11 23:01:36

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who allegedly suffered dangerous episodes of internal bleeding due to Pradaxa. New York, New York (PRWEB) April 11, 2014 As thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward in federal court, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has approved a new indication for the blood thinner. According to an April 7th announcement from Boehringer...

2014-04-08 23:01:01

Dr. Revana, at Northeast Houston Vein Center, is working to educate his peers on the challenging diagnosis of pelvic congestion syndrome as well as other conditions affecting veins. Humble, TX (PRWEB) April 08, 2014 Northeast Houston Vein Center recently began working to educate doctors on the issue of pelvic congestion syndrome (PCS) and other vein issues. Dr. Madaiah Revana is leading the effort on spreading the word about this tough condition. The facility now provides training to...

2014-04-02 08:32:43

MUNICH, Germany, April 2, 2014 /PRNewswire/ -- For European Media Only, Not for UK Media Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a five-fold increased risk of stroke compared with the general population[2] Daiichi Sankyo today announced its commitment to extend the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). The extension of the registry will include a specific...

2014-03-31 08:28:47

First patient enrolled in largest planned phase 3 study evaluating a novel oral anticoagulant in non-valvular atrial fibrillation patients undergoing electrical cardioversion PARSIPPANY, N.J., March 31, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor...

2014-03-28 08:22:23

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/xvt3hx/investigation ) has announced the addition of the "Investigation Report on China Enoxaparin Sodium Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of...

2014-03-25 23:00:43

The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes and other dangerous cardiovascular problems, allegedly due to the use of drugs like Testim and AndroGel. New York, New York (PRWEB) March 25, 2014 A second testosterone treatment lawsuit (http://www.testosteronelawsuitcenter.com/) has been filed in Pennsylvania on behalf of a man who allegedly suffered serious cardiovascular problems due to his use of Testim. According to the...

2014-03-24 20:23:44

The International Society on Thrombosis and Haemostasis partners with thrombosis related organizations from every continent to launch World Thrombosis Day focused on single cause of top 3 cardiovascular deaths worldwide CHAPEL HILL, N.C., March 24, 2014 /PRNewswire-USNewswire/ -- Bringing together nations and local communities to tackle thrombosis, the quiet, underlying disorder that is the common mechanism of the world's three top cardiovascular killers - heart attack, stroke and venous...

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from three company-sponsored PRADAXA studies will be presented at the American College of Cardiology 63(rd) Annual Scientific Session (ACC.14) in Washington, D.C., March 29 to 31, 2014. An oral presentation will...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related